The biology of the parasite compounds the problem. H. contortus follows a direct life cycle characterized by fecal-oral transmission, with a pre-patent period of just 17 to 21 days. Infective larvae ingested from pasture mature into blood-feeding adults in the abomasum, and the eggs shed in feces rapidly contaminate grazing land, perpetuating the cycle. This prolific reproductive capacity means that pasture contamination can escalate quickly, and it explains why a single grazing season can transform a modest infection into a herd-level crisis. Without effective intervention, the parasite’s speed and fecundity overwhelm the defenses of susceptible animals.

For decades, the primary weapon against H. contortus has been anthelmintic drugs, which fall into three major classes: benzimidazoles, cholinergic agonists, and macrocyclic lactones. Widespread and often indiscriminate use of these compounds, however, has driven the emergence of multidrug resistance within parasite populations. Genetic modifications in H. contortus have altered effective drug targets, changed physiochemical interactions, and modified drug distribution within the worm, rendering once-reliable treatments increasingly ineffective. The combination of the parasite’s prolific nature and the shrinking arsenal of effective drugs highlights an urgent need for improved control strategies that do not depend solely on chemical treatment.

Paradoxically, the solution may already exist within the sheep genome itself. Sheep were among the first animals domesticated by humans, and although all breeds share a common ancestor, substantial genetic diversity between breeds influences economically relevant traits ranging from carcass and wool characteristics to disease resistance. Natural resistance against H. contortus has been documented most prominently in hair sheep breeds, which originate from humid tropical climates where constant parasite pressure acted as a powerful selective force. By contrast, wool breeds developed in the cooler environment of Europe were selected for production traits without that environmental pressure against parasitism, leaving them markedly more susceptible to infection.

The differences between these breed groups are striking when measured directly. Hair sheep breeds such as the St. Croix, Gulf Coast Native, and Barbados Blackbelly demonstrate higher levels of resistance to H. contortus, shown by increased packed cell volumes and decreased fecal egg counts and worm burdens in the abomasum at necropsy compared with European wool breeds such as the Suffolk and Dorset. Comparative studies among the resistant tropical breeds revealed that the St. Croix displays the highest resistance of all, outperforming Gulf Coast Native, Barbados Blackbelly, and crossbred wool sheep. This exceptional phenotype makes the St. Croix an ideal model for studying natural parasite resistance, although the breed lacks many economically desirable production traits, underscoring the importance of understanding the mechanisms that drive resistance so they can be introduced into more productive lines.

Host genetics is a major contributor to variation in resistance, even though factors such as sex, age, and previous exposure also play roles. Evidence for a genetic basis comes from the marked differences observed both between breeds and among individuals within the same breed. One practical example is the Katahdin, a breed originally developed in the 1950s by crossing parasite-resistant St. Croix hair sheep with production-oriented breeds including the Suffolk and Wiltshire Horn. Although Katahdins are widely regarded as parasite resistant, considerable variation exists in post-weaning fecal egg count estimated breeding values among them, revealing substantial room for continued genetic improvement through selective breeding.

The genetics of resistance, however, is far from simple. Post-weaning fecal egg count is moderately heritable, with estimates ranging from 0.23 to 0.46, yet parasite resistance behaves as a complex, polygenic trait shaped by many genes rather than a single major locus. No single resistance gene has been identified; genome-wide association studies and regional heritability mapping in sheep have instead pointed to multiple genomic regions contributing to the phenotype. This distributed genetic architecture means that understanding how these differences influence immune function remains a critical and active area of research, one that must bridge population genetics and immunology before breeding programs can fully exploit natural resistance.

What is clear is that resistance is immunologically mediated. Natural resistance to H. contortus acts against the infective L3 larval stage, preventing the establishment of adult worms in the abomasum without any reliance on anthelmintic drugs. Gastrointestinal nematodes generally elicit a T-helper 2 type immune response in the host, characterized by production of the key cytokines interleukin-4, IL-5, and IL-13, which mediate host protection. In resistant St. Croix sheep, this Th2 response develops early in the abomasum and is marked by increased eosinophilia, mastocytosis, elevated IgG and IgA, and robust production of IL-4, IL-5, and IL-13. The centrality of adaptive immunity is demonstrated by depletion experiments: removing CD4-positive T cells from resistant sheep resulted in increased fecal egg counts and worm burdens, confirming that resistance depends on mounting the appropriate adaptive response in time.

Timing appears to be the decisive difference between resistant and susceptible animals. In susceptible breeds such as the Suffolk, the immune response to H. contortus is delayed, permitting the parasite to establish itself and forcing farmers to rely on anthelmintic treatment to prevent mortality. This suggests that differences in the speed and magnitude of the host immune response are the mediating factor separating the resistant from the susceptible phenotype. Despite the identification of these robust Th2-like responses in resistant sheep, the exact mechanisms that initiate and amplify them in St. Croix animals remain unknown, representing one of the central unanswered questions in the field.

Alternative control methods offer only partial relief. Copper oxide wire particles have gained popularity over the past decade, but their anthelmintic activity in infected lambs is relatively short-lived, lasting up to 35 days, and treatment often still requires conventional drugs. Barbervax, the only commercially available vaccine against H. contortus, is approved in Australia, the United Kingdom, and South Africa, but its variable efficacy and high economic cost illustrate the difficulty of vaccine development for this parasite. In parasite-susceptible Merino sheep, Barbervax achieved a 60 to 75 percent decrease in fecal egg counts under low and moderate trickle infections of 300 and 600 infective larvae per week, yet it failed to confer protection under high-level exposure of 1,200 or 2,400 larvae per week. Because vaccination may not protect animals facing heavy infections or heavily contaminated pasture, alternative strategies are essential. In this context, the parasite-resistant St. Croix sheep stands out as an ideal model for elucidating how the early Th2-like response is amplified, allowing researchers to characterize the initiators and mechanisms that drive resistance during infection. A deeper understanding of the Th2-type immune response in resistant sheep is expected to inform the development of cellular and cytokine-based immunotherapy strategies, offering a path toward controlling H. contortus without the dependence on anthelmintic drugs that has fueled the current resistance crisis.

Subject of Research: Natural genetic and immunological resistance to the blood-feeding nematode Haemonchus contortus in sheep breeds

Article Title: Born to resist: Understanding natural resistance to Haemonchus contortus in sheep

Article References: Teddleton, H., & Shepherd, E. (2026). Born to resist: Understanding natural resistance to Haemonchus contortus in sheep. PLOS Pathogens, 22(10), e1014658. https://doi.org/10.1371/journal.ppat.1014658

Image Credits: AI Generated

DOI: 10.1371/journal.ppat.1014658

Keywords: Haemonchus contortus, sheep, parasite resistance, hair sheep, St. Croix, Th2 immune response, anthelmintic resistance, genetics, Katahdin, Barbervax, gastrointestinal nematodes, immunology

The question matters because prurigo nodularis is far from rare and far from benign. Clinicians have historically viewed it as a disfiguring, quality-of-life-destroying disorder driven by a self-perpetuating itch-scratch cycle, but over the past decade a growing body of work has suggested that the disease may travel with systemic baggage. Earlier clinical observations, including a widely cited 2019 analysis in the Journal of the American Academy of Dermatology by Larson and colleagues, reported an association between prurigo nodularis and malignancy in middle-aged adults, prompting dermatologists to wonder whether the condition might serve as a cutaneous flag for internal disease. Subsequent systematic reviews, including a 2025 meta-analysis by Chang and Chiu in the Journal of the European Academy of Dermatology and Venereology, have examined the risk of malignancy in prurigo nodularis patients, keeping the controversy alive in the literature.

What has made the field difficult is confounding. Patients with prurigo nodularis tend to be older, more likely to have atopic dermatitis and other inflammatory conditions, more likely to take immunomodulating drugs, and more likely to see physicians frequently, which increases the chance that any cancer will simply be noticed. A naive comparison of cancer rates between prurigo nodularis patients and the general population could therefore exaggerate or even invent an association. This is precisely the methodological trap that propensity score matching is designed to defuse. By estimating each participant’s probability of having prurigo nodularis based on measured characteristics, and then matching each case to controls with similar probabilities, the technique creates two groups that are statistically balanced on the measured confounders, allowing the disease itself to be isolated as the variable of interest.

The data infrastructure behind the new analysis is as important as the statistics. The All of Us Research Program, launched by the National Institutes of Health and described in the New England Journal of Medicine in 2019 by Denny and colleagues, aims to enroll at least one million Americans and deliberately prioritizes populations that have been underrepresented in biomedical research. Its curated database links electronic health records, survey responses, and physical measurements, giving researchers a way to study real-world patient populations at a scale that single-center clinics cannot match. For a condition like prurigo nodularis, which is often underdiagnosed and inconsistently coded, access to a large, diverse cohort is a meaningful advantage over the smaller case series that dominated the earlier literature.

Using this resource, the Baylor team constructed a cohort of individuals with prurigo nodularis and a matched comparison group without the disease, then tracked the occurrence of skin cancer across the two groups. The outcome of interest, skin cancer, encompasses both keratinocyte malignancies such as basal cell and squamous cell carcinoma and the more dangerous melanoma, and the researchers’ framing of the study reflects a broader question in dermatology: whether chronic Th2-skewed inflammatory dermatoses, the immune signature that prurigo nodularis shares with atopic dermatitis, alter cancer surveillance and tumor biology in the skin. A 2025 review in the International Journal of Molecular Sciences underscored the central role of type 2 immune responses in inflammatory dermatoses, from pathogenesis to the new wave of targeted therapies, providing a biological rationale for why chronic itch disorders might intersect with oncology.

The study’s findings, presented as a research letter rather than a full-length paper, should be read with an appreciation of both their strengths and their limits. Research letters are compact formats that report focused analyses, and the authors are explicit that their work is observational. Propensity score matching balances the confounders that are measured, but it cannot eliminate residual confounding by factors that were never recorded, such as lifetime ultraviolet exposure, sun-protection behavior, or the precise duration and severity of itch. Skin cancer risk is overwhelmingly driven by ultraviolet radiation, and any study that cannot fully adjust for sun exposure must interpret its own associations with appropriate humility. The authors declare no conflicts of interest relevant to the work, and the research received no specific grant funding from public, commercial, or not-for-profit agencies.

Nevertheless, the direction of the evidence is becoming harder to ignore. The new All of Us analysis lands in a literature that has repeatedly circled the same question from different angles: clinic-based series suggesting excess malignancy, meta-analyses attempting to pool the signal, and now a large, matched, nationally representative cohort designed specifically to neutralize demographic and comorbidity differences. Convergent findings across independent datasets and methods are how epidemiology builds confidence, and the Baylor study adds a methodologically careful data point to that convergence. For dermatologists, the practical implication is that prurigo nodularis may deserve a place in the same conversation as other inflammatory skin diseases, such as severe psoriasis and atopic dermatitis, for which guidelines increasingly recommend attention to comorbidity screening.

The biological plausibility of a link deserves scrutiny as well. Chronic inflammation is a recognized contributor to carcinogenesis across many tissues, and the skin is no exception: inflamed microenvironments supply proliferative signals, oxidative stress, and immune modulation that can favor tumor initiation and progression. Prurigo nodularis lesions are characterized by thickened, hyperproliferative epidermis, nerve fiber proliferation, and a persistent type 2 immune infiltrate, and many patients are treated with systemic agents that modulate immunity. Whether the association with skin cancer, if confirmed, reflects shared inflammatory pathways, behavioral factors such as scratching and skin barrier disruption, surveillance bias, or the effects of immunosuppressive therapy remains an open question that the research letter cannot resolve on its own.

What the study does resolve is the feasibility of asking these questions at scale. By demonstrating that the All of Us Research Program can support propensity score–matched analyses of an underrecognized skin disease, the Baylor team has opened a template for follow-up work: larger cohorts, longer follow-up, subtype-specific cancer outcomes, and stratification by race, ethnicity, and skin type, where the burden of prurigo nodularis is known to be disproportionately high among Black and other patients of color yet where melanoma detection patterns differ. The authors, based at Baylor College of Medicine and McGovern Medical School at UTHealth Houston, note that the manuscript went through revision and was accepted in September 2026, reflecting an active and current debate in the dermatology community.

For patients living with the relentless itch of prurigo nodularis, the message from this research is not alarm but attention. The disease is already associated with anxiety, depression, sleep loss, and profound impairment of daily life, and the possibility of an added cancer risk gives patients and clinicians one more reason to pursue early diagnosis and aggressive, modern treatment, including the biologic therapies now reshaping the field. At the same time, the study is a reminder of how much remains unknown: an association established in a matched cohort is a signal to investigate, not a prescription for panic. As the All of Us database continues to grow and as targeted anti-itch therapies generate new natural experiments in immune modulation, the coming years should clarify whether prurigo nodularis truly belongs on the list of inflammatory skin diseases with oncologic consequences, and if so, what mechanisms connect a scratch to a tumor.

Subject of Research: Association between prurigo nodularis and skin cancer risk in a propensity score–matched cohort from the All of Us Research Program

Article Title: Association between prurigo nodularis and skin cancer: a propensity score–matched cohort study using the all of us research program

Article References: K Joe, M., Husseinali, M., & A Wasko, C. (2026). Association between prurigo nodularis and skin cancer: a propensity score–matched cohort study using the all of us research program. Archives of Dermatological Research, 318(1), Article 509. https://doi.org/10.1007/s00403-026-04989-7

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04989-7

Keywords: prurigo nodularis, skin cancer, All of Us Research Program, propensity score matching, dermatology, chronic itch, melanoma, inflammatory skin disease, epidemiology, cohort study, Th2 immune response, comorbidity